Single cell transcriptomic analysis of Graves’ disease thyroid glands reveals the broad immunoregulatory potential of thyroid follicular and stromal cells and implies a major re-interpretation of the role of aberrant HLA class II expression in autoimmunity

• Published in: Journal of autoimmunity 2023-09, Vol.139, p.103072-103072, Article 103072
• Main Authors: Álvarez-Sierra, Daniel, Rodríguez-Grande, Jorge, Gómez-Brey, Aroa, Bello, Irene, Caubet, Enric, González, Óscar, Zafón, Carles, Iglesias, Carmela, Moreno, Pablo, Ruiz, Núria, Marín-Sánchez, Ana, Colobran, Roger, Pujol-Borrell, Ricardo
• Format: Article
• Language: English
• Subjects: Adaptative immunity; Peripheral tolerance; Thyroid autoimmunity
• ISSN: 0896-8411; 1095-9157
• DOI: 10.1016/j.jaut.2023.103072

The study of the immune response in thyroid autoimmunity has been mostly focused on the autoantibodies and lymphocytes, but there are indications that intrinsic features of thyroid tissue cells may play a role in disrupting tolerance that needs further investigation. The overexpression of HLA and adhesion molecules by thyroid follicular cells (TFC) and our recent demonstration that PD-L1 is also moderately expressed by TFCs in autoimmune thyroid indicates that TFCs they may activate but also inhibit the autoimmune response. Intriguingly, we have recently found that in vitro cultured TFCs are able to suppress the proliferation of autologous lymphocyte T in a contact-dependent manner which is independent of the PD-1/PD-L1 signaling pathway. To get a more comprehensive picture of TFC activating and inhibitory molecules/pathways driving the autoimmune response in the thyroid glands, preparations of TFCs and stromal cells from five Graves’ disease (GD) and four control thyroid glands were compared by scRNA-seq. The results confirmed the previously described interferon type I and type II signatures in GD TFCs and showed unequivocally that they express the full array of genes that intervene in the processing and presentation of endogenous and exogeneous antigens. GD TFCs lack however expression of costimulatory molecules CD80 and CD86 required for priming T cells. A moderate overexpression of CD40 by TFCs was confirmed. GD Fibroblasts showed widespread upregulation of cytokine genes. The results from this first single transcriptomic profiling of TFC and thyroid stromal cells provides a more granular view of the events occurring in GD. The new data point at an important contribution of stromal cells and prompt a major re-interpretation of the role of MHC over-expression by TFC, from deleterious to protective. Most importantly this re-interpretation could also apply to other tissues, like pancreatic beta cells, where MHC over-expression has been detected in diabetic pancreas. •Thyroid transcriptional changes are driven by IFN II response signature.•Proinflammatory cytokines and chemokines are expressed in control thyroids.•Thyrocytes in autoimmune expressed HLA genes but no costimulatory molecules.•Immunoregulatory genes are expressed by control and autoimmune thyrocytes.•Wound healing and structural signaling pathways are enhanced in autoimmunity.